Alpha RegistryClaim a profile
Published mark

MANNKIND CORP

NASDAQ: MNKD. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:a2c00416-8b51-4f2c-8df3-b88344428b91
SEC CIK
0000899460
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
Newest evidence
May 3, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Michael E. CastagnaSince Feb 26, 2026
Chair
James S. Shannon, M.D.
Independent
Not published9 directors published
Published claims
314 distinct sources
Evidence records
100 pinned
Source conflicts
0None open

Built from 4 distinct sources and 10 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Amrita Ahuja executive of MANNKIND CORP, effective 2026-02-26.

EffectiveEffective Feb 26, 2026E5

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Executive Vice President and Chief Medical OfficerAmrita AhujaFeb 2026currentSource reportedE5
General Counsel and SecretaryDavid B. ThomsonFeb 2026currentSource reportedE6
Chief Executive OfficerMichael E. CastagnaFeb 2026currentSource reportedE7
Executive Vice President, Human ResourcesStuart A. TrossFeb 2026currentSource reportedE9
Executive Vice President, Chief Medical OfficerAjay Ahuja, M.D.Not capturedunknownSource reportedE2
Executive Vice President and Chief Medical OfficerAjay Ahuja, M.D., MBANot capturedunknownSource reportedE4
Chief Financial OfficerChristopher B. PrentissNot capturedunknownSource reportedE2
Executive Vice President, General Counsel and SecretaryDavid B. Thomson, Ph.D., J.D.Not capturedunknownSource reportedE2
President, Endocrine Business UnitDominic MarascoNot capturedunknownSource reportedE2
Chief Executive OfficerMichael E. Castagna, Pharm.D.Not capturedunknownSource reportedE2
Executive Vice President, Technical OperationsSanjay SinghNot capturedunknownSource reportedE2
Executive Vice President, Technical OperationsSanjay Singh, M Pharm, MBANot capturedunknownSource reportedE8
Executive Vice President, Human ResourcesStuart A. Tross, Ph.D.Not capturedunknownSource reportedE2

Board of directors

Evidence

9 directors published. Independence determinations are not published for every director.

DirectorStatusSinceCommitteesClaim
Anthony HooperIndependence not published2020None publishedSource reportedE3
Christine MundkurIndependence not published2018None publishedSource reportedE3
James S. ShannonIndependence not published2015Chair of the Board of Directors Member, Compensation Committee, chairSource reportedE3
Jennifer GrancioIndependence not published2020None publishedSource reportedE3
Michael A. FriedmanIndependence not published2003None publishedSource reportedE3
Michael E. CastagnaIndependence not published2017None publishedSource reportedE3
Ronald J. ConsiglioIndependence not published2003None publishedSource reportedE3
Sabrina KayIndependence not published2020None publishedSource reportedE3
Steven B. BinderIndependence not published2024None publishedSource reportedE3
James S. Shannon, M.D.IndependentChairNot publishedNone publishedSource reportedE2
Michael A. Friedman, M.D.IndependentNot publishedNone publishedSource reportedE2
Sabrina Kay, Ed.D.IndependentNot publishedNone publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
Chair of the Board of Directors Member, Compensation CommitteeJames S. ShannonJames S. ShannonNot described in the published record
Committee RecordChair of the Board of Directors Member, Compensation Committee: Chair James S. Shannon; Members James S. Shannon (Chair)
Source reportedE10
company:a2c00416-8b51-4f2c-8df3-b88344428b91:committee_record:30
Committee AppointmentJames S. Shannon: chair, Chair of the Board of Directors Member, Compensation Committee
Source reportedE10
company:a2c00416-8b51-4f2c-8df3-b88344428b91:committee_appointment:31

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerMichael E. Castagna, Chief Executive Officer, from Feb 26, 2026
Source reportedE7
company:a2c00416-8b51-4f2c-8df3-b88344428b91:leadership_role:24
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingMNKD (NASDAQ)
Source reportedE1
company:a2c00416-8b51-4f2c-8df3-b88344428b91:security_listing:32
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 18, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameMANNKIND CORP
Source reportedE1
company:a2c00416-8b51-4f2c-8df3-b88344428b91:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:a2c00416-8b51-4f2c-8df3-b88344428b91:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
10 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    SEC DEF 14A 0001193125-26-145613
    sec def 14a. Published Apr 7, 2026. Retrieved Sep 6, 2026. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    DEF 14A mnkd-20260407.htm
    sec proxy. Published Apr 7, 2026. Retrieved Sep 2, 2026. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    MNKD executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    MNKD 10-K executive officers
    sec filing. Published Feb 26, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    MNKD 10-K executive officers
    sec filing. Published Feb 26, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    MNKD 10-K executive officers
    sec filing. Published Feb 26, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    MNKD executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    MNKD 10-K executive officers
    sec filing. Published Feb 26, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    Chair of the Board of Directors Member, Compensation Committee
    governance_people_committees. sec proxy. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 17, 2026
  • Amrita Ahuja executive of MANNKIND CORP, effective 2026-02-26.
  • David B. Thomson executive of MANNKIND CORP, effective 2026-02-26.
  • Michael E. Castagna executive of MANNKIND CORP, effective 2026-02-26.
  • Stuart A. Tross executive of MANNKIND CORP, effective 2026-02-26.
  • Steven B. Binder seat on MANNKIND CORP, effective 2024-01-01.
  • Anthony Hooper seat on MANNKIND CORP, effective 2020-01-01.
  • Jennifer Grancio seat on MANNKIND CORP, effective 2020-01-01.
  • Sabrina Kay seat on MANNKIND CORP, effective 2020-01-01.
  • Christine Mundkur seat on MANNKIND CORP, effective 2018-01-01.
  • Michael E. Castagna seat on MANNKIND CORP, effective 2017-01-01.
  • James S. Shannon seat on MANNKIND CORP, effective 2015-01-01.
  • Michael A. Friedman seat on MANNKIND CORP, effective 2003-01-01.
  • Ronald J. Consiglio seat on MANNKIND CORP, effective 2003-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:a2c00416-8b51-4f2c-8df3-b88344428b91, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/mannkind-corp

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership13
  4. Board12
  5. Committees1
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people24
  17. Subject and corrections6
  18. Evidence10
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:a2c00416-8b51-4f2c-8df3-b88344428b91
  • Cite this recordMANNKIND CORP
  • Copy canonical URLregistry.alpha.ac/companies/mannkind-corp
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    MANNKIND CORPCompany
  • Amrita AhujaPerson
  • David B. ThomsonPerson
  • Michael E. CastagnaPerson
  • Stuart A. TrossPerson
  • Ajay Ahuja, M.D.Person
  • Ajay Ahuja, M.D., MBAPerson
  • Christopher B. PrentissPerson
  • David B. Thomson, Ph.D., J.D.Person
  • Dominic MarascoPerson
  • Michael E. Castagna, Pharm.D.Person
  • Sanjay SinghPerson
  • Sanjay Singh, M Pharm, MBAPerson
  • Stuart A. Tross, Ph.D.Person
  • Anthony HooperPerson
  • Christine MundkurPerson
  • James S. ShannonPerson
  • Jennifer GrancioPerson
  • Michael A. FriedmanPerson
  • Ronald J. ConsiglioPerson
  • Sabrina KayPerson
  • Steven B. BinderPerson
  • James S. Shannon, M.D.Person
  • Michael A. Friedman, M.D.Person
  • Sabrina Kay, Ed.D.Person
  • Sections
    OverviewMANNKIND CORP
  • MonitoringMANNKIND CORP
  • LeadershipMANNKIND CORP
  • BoardMANNKIND CORP
  • CommitteesMANNKIND CORP
  • Control and votingMANNKIND CORP
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.